Consumer Health

Wound care tends to show high demand during the summer when more skin is exposed and opportunities for outdoor leisure and sports activities increase, with this increasing the risk of picking up injuries. Sales of wound care therefore benefited in…

Demand for weight management and wellbeing products has continued to grow in the wake of the pandemic as consumers have looked to shed the weight gained during lockdown and home seclusion, but also due increased health consciousness. Although having…

Sales of multivitamins and single vitamins in Japan have continued to grow in current value terms in 2023, reflecting the ongoing consumer interest in healthy living. Multivitamins are seen as an easy and convenient way for consumers to address their…

Sports nutrition was one of the most dynamic areas of consumer health in Japan over the review period, including during and after the pandemic. The category has been rapidly expanding thanks to an increasingly health conscious population, but also…

The potential market for sleep aids is expanding in Japan off the back of an increasing number of consumers facing poor sleep quality and fewer hours of sleep. This drop in quality sleep is due in part to a rise in telecommuting and prolonged use of…

Overall, sales of paediatric consumer health are in decline in current value terms in Japan in 2023. Nonetheless, the performances vary by product category with some benefiting from a post-pandemic recovery while others are facing headwinds. For…

Regulations against smoking are becoming stricter worldwide, and the situation is no different in Japan. These stricter rules have encouraged large numbers of smokers to quit, especially since the law banning smoking indoors in principle (Health…

In 2023, with COVID-19 moving to a class 5 disease and restrictions on social behaviour being lifted, consumers started to go out without wearing masks, leading to an increase in influenza, infectious diseases with cough symptoms, and heat stroke. In…

With the pandemic declared to be over in 2023, sales of both standard eye care and allergy eye care have benefited from increased opportunities to get out and about, a recovery in the number of inbound travellers, but also high pollen counts.…

Sales of digestive remedies continue to see a strong recovery in 2023 in current value terms. Sales are rebounding from the negative impact of the pandemic with the lifting of restrictions increasing the opportunities for consumers to go out to eat…

Similar to the pattern seen in vitamins, sales of dietary supplements continue to see steady growth in current value terms in 2023 due to increasing health consciousness. The market has been hit by the rising cost of raw materials and production…

Dermatologicals has seen a return to growth in current value terms in 2023, which is mainly due to the waning impact of COVID-19 on consumer lifestyles and behaviours. Antipruritics is one of the largest categories within dermatologicals and has also…

Sales of cough, cold and allergy (hay fever) remedies in Japan have continued to recover in 2023. This is largely due to increased opportunities for consumers to go out and a shift away from the practice of wearing face masks on a daily basis. With…

Sales of OTC products in Japan continue on the path to recovery in 2023 as the country sees an end to the pandemic. With the World Health Organisation (WHO) declaring the pandemic to be over in early 2023 there have been increased opportunities to go…

Sales of analgesics in Japan have seen solid growth in current value terms in 2023 backed by increased opportunities for consumers to go out, the recovery in the number of inbound tourists, and a move away from the practice of wearing face masks on a…

This report examines inflation levels and drivers globally and in key countries. In 2023, global inflation is expected to ease from its peak in 2022, but remaining significantly above-trend. Geopolitical risks and uncertainty in the energy market are…

In 2021, Asia Pacific ranked first globally in terms of production output of pharmaceuticals and medical equipment, with a turnover of USD857 billion. Over 2021-2030, the region is expected to record the fastest production growth globally,…

This report examines inflation levels and drivers globally and in key countries. Global inflation is reaching a peak, although geopolitical risks and uncertainty in the energy market remain key risks. The impact varies between countries, with…

This report examines inflation levels and drivers globally and in key countries. Global inflation is reaching a peak, although geopolitical risks and uncertainty in the energy market remain key risks. The impact varies between countries, with…

This briefing examines how the healthcare and social services industry is performing globally and in the largest countries in terms of healthcare and social services output. The report also provides data for production, market size, imports, exports,…